Carbon-ion radiotherapy for the lacrimal gland carcinomas extending to extra-orbital tissues

Carbon-ion radiotherapy for the lacrimal gland carcinomas extending to extra-orbital tissues - Carbon-ion radiotherapy for the lacrimal gland carcinomas

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000029314

Enrollment

Registered

2017-10-09

Start date

2017-10-09

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

the lacrimal gland carcinoma

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) a histologically proven carcinoma of the lacrimal gland extending to extra-orbital tissues 2) measurable carcinoma 3) performance status 0-2 4) no systemic therapy, such as chemotherapy, within 1 month of commencing re-irradiation with CIRT 5) N0M0 or N1M0

Exclusion criteria

Exclusion criteria: co-existent malignant active tumor

Design outcomes

Primary

Measure	Time frame
Local control rate	—

Countries

Japan

Contacts

Public ContactHayashi Kazuhiko

National Institutes for Quantum and Radiological Sciences and Technology Hospital of the National Institute of Radiological Sciences

kazuhiko.hayashi@qst.go.jp043-206-3360

Outcome results